Physician Finder

Contact an expert treatment center offering minimally-invasive anti-reflux therapies.

Learn
About Reflux

For Patients & Families

Learn more about gastroesophageal reflux disease (GERD), common symptoms, causes, and treatment options.

For

Health Care
Professionals

Read about clinical experience and latest studies of EndoStim LES Stimulation Therapy for GERD.






Learn about our FDA clinical trial in the United States.







EndoStim in the News

Endostim featured in the news on NDR Aktuell in Germany

NDR, June 2016

New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease (GERD) presented at Digestive Disease Week® 2016

PR Newswire, May 2016

EndoStim Names Rohan Hoare, Ph.D., as New President and CEO

PR Newswire, May 2016

EndoStim Secures $25 Million in Funding to Expand Commercialization Efforts and Conduct a Pivotal U.S. Clinical Trial

PR Newswire, May 2016

EndoStim's Neurostimulation Therapy for Gastroesophageal Reflux Disease Approved in Brazil

PR Newswire, Dec 2015

EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System

PR Newswire, Oct 2015

EndoStim's neurostimulation therapy for GERD receives permanent reimbursement coverage in Germany

PR Newswire, Oct 2015

International Multicenter Trial results of EndoStim LES Stimulation therapy confirm safety and efficacy in patients with GERD

PR Newswire, July 2015

EndoStim Launches Second Generation Neurostimulation Device for GERD

PR Newswire, May 2015

EndoStim Therapy for Gastroesophageal Reflux Disease Launched in Mexico

PR Newswire, May 2015

Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville.

PR Newswire, May 2015